Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001896206-25-000007·AEON Biopharma, Inc.
Schedule 13G ownership disclosure
AEON BIOPHARMA INC
Common Stock · CUSIP: 00791X209
Event date: 2025-09-30
- Filing-level shares
- 249,870.00
- Percent of class
- 2.1%
- Alta Partners LLC
Shares: 249,870.00 · Class: 2.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001896206-25-000007
- Form type
- SCHEDULE 13G/A
- Filer
- AEON Biopharma, Inc.
- CIK
- CIK 1837607
- Filed
- Oct 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership